Biochemical response is associated with liver stiffness stability in patients with primary biliary cholangitis treated with seladelpar for up to 3 years in the ongoing open-label ASSURE study

Conference Reports for NATAP

EASL - European Association
for the Study of the Liver
Barcelona, Spain
May 27-30, 2026


Biochemical response is associated with liver stiffness stability in patients with primary biliary cholangitis treated with seladelpar for up to 3 years in the ongoing open-label ASSURE study

	EASL 2026 May 26-30 Barcelona Gideon M. Hirschfield1*,